moxisylyte has been researched along with Chronic Primary Open Angle Glaucoma in 2 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thymoxamine is a selective alpha sympathetic blocking agent which may be used to stop the mydriasis induces by phenylephrine, ("safe mydriasis"), to differentiate an open but narrow angle glaucoma from an angle closure glaucoma, to treat an acute closure and to induce miosis without shallowing of the anterior chamber before laser trabeculoplasty." | 3.66 | [Thymoxamine and angle-closure glaucoma]. ( Etienne, R, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Etienne, R | 1 |
| Dake, CL | 1 |
2 other studies available for moxisylyte and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
[Thymoxamine and angle-closure glaucoma].
Topics: Anterior Chamber; Diagnosis, Differential; Glaucoma; Glaucoma, Open-Angle; Humans; Moxisylyte; Pheny | 1983 |
Argon-laser coagulation of the scleral spur (L.S.S.C.) in primary open-angle glaucoma and pigment glaucoma.
Topics: Aged; Anterior Chamber; Argon; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Laser Therapy; Middl | 1984 |